Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (61-70 of 349) with videos related to

Pageof 35
Sort By:
Pharmacology & Toxicology|April 1, 1997
The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disordersM Gassen, M B Youdim
Scientific American|January 1, 1997
Understanding Parkinson's diseaseM B Youdim, P Riederer
Lancet (London, England)|September 3, 1977
Monoamine-oxidase inhibitors and prolactin secretionJ Mendlewicz, M B Youdim
The American Journal of Clinical Nutrition|September 1, 1989
Brain iron: a lesson from animal modelsS Yehuda, M B Youdim
British Journal of Pharmacology|May 1, 1979
A nucleotide with characteristic platelet aggregation and inhibition properties similar to 5-hydroxytryptamine [proceedings]B Oppenheim, M B Youdim
Essays in Neurochemistry and Neuropharmacology|January 1, 1977
The isolated perfused rat brain preparation--a critical assessmentH F Woods, M B Youdim
The Proceedings of the Nutrition Society|September 1, 1978
Iron deficiency and neurotransmitter synthesis and functionM B Youdim, A R Green
Journal of Neurochemistry|April 1, 1990
Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivityD Ben-Shachar, M B Youdim
British Journal of Pharmacology|January 1, 1976
Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lungY S Bakhle, M B Youdim
Journal of Neural Transmission. Supplementum|January 1, 1990
Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interactionD Ben-Shachar, M B Youdim
Pageof 35

Showing results (61-70 of 349) with videos related to

Sort By:
Pageof 35
Pharmacology & Toxicology|April 1, 1997
The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disordersM Gassen, M B Youdim
Scientific American|January 1, 1997
Understanding Parkinson's diseaseM B Youdim, P Riederer
Lancet (London, England)|September 3, 1977
Monoamine-oxidase inhibitors and prolactin secretionJ Mendlewicz, M B Youdim
The American Journal of Clinical Nutrition|September 1, 1989
Brain iron: a lesson from animal modelsS Yehuda, M B Youdim
British Journal of Pharmacology|May 1, 1979
A nucleotide with characteristic platelet aggregation and inhibition properties similar to 5-hydroxytryptamine [proceedings]B Oppenheim, M B Youdim
Essays in Neurochemistry and Neuropharmacology|January 1, 1977
The isolated perfused rat brain preparation--a critical assessmentH F Woods, M B Youdim
The Proceedings of the Nutrition Society|September 1, 1978
Iron deficiency and neurotransmitter synthesis and functionM B Youdim, A R Green
Journal of Neurochemistry|April 1, 1990
Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivityD Ben-Shachar, M B Youdim
British Journal of Pharmacology|January 1, 1976
Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lungY S Bakhle, M B Youdim
Journal of Neural Transmission. Supplementum|January 1, 1990
Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interactionD Ben-Shachar, M B Youdim
Pageof 35